Syphilis, a systemic infection caused by the bacterium Treponema pallidum, requires a precise and timely Diagnosis Of Syphilis to ensure effective treatment and prevent severe complications. The disease progresses through distinct stages, each characterized by unique clinical manifestations that guide diagnostic approaches and subsequent management. Understanding these stages and the corresponding diagnostic methods is crucial for healthcare professionals.
Syphilis can present with a wide spectrum of symptoms. Primary syphilis is typically marked by a painless chancre, a solitary ulcer at the site of infection, though atypical, multiple, or painful lesions can also occur. Secondary syphilis can manifest with a diffuse skin rash, mucocutaneous lesions, and lymphadenopathy. Tertiary syphilis, the late stage of the disease, may involve the cardiovascular system, causing cardiac syphilis, or the nervous system, leading to neurosyphilis with gummatous lesions, tabes dorsalis, and general paresis.
Latent syphilis, an asymptomatic phase, is diagnosed solely through serologic testing. Early latent syphilis refers to infections acquired within the past year, while late latent syphilis or latent syphilis of unknown duration encompasses all other cases lacking clinical signs.
T. pallidum can invade the central nervous system (CNS) at any stage, resulting in neurosyphilis. Early neurosyphilis, often occurring within months to a few years of infection, may present as syphilitic meningitis with symptoms like cranial nerve dysfunction, meningitis, meningovascular syphilis, stroke, and acute altered mental status. Late neurosyphilis, developing decades after infection (10 to 30+ years), includes tabes dorsalis and general paresis.
Ocular syphilis, affecting the visual system, and otosyphilis, affecting the auditory system, can occur at any stage but are frequently diagnosed in the early stages, sometimes without concurrent CNS involvement. Ocular syphilis commonly manifests as panuveitis but can affect various parts of the eye, potentially causing conjunctivitis, anterior uveitis, posterior interstitial keratitis, optic neuropathy, and retinal vasculitis, potentially leading to permanent vision loss. Otosyphilis typically presents with cochleovestibular symptoms such as tinnitus, vertigo, and sensorineural hearing loss, which can be sudden, rapidly progressive, unilateral or bilateral, and may result in permanent hearing impairment.
Definitive Diagnostic Methods for Early Syphilis
For the diagnosis of syphilis, particularly in its early stages and in cases of congenital syphilis, direct detection methods are paramount. Darkfield microscopy and molecular tests are considered definitive for identifying T. pallidum directly from lesion exudate or tissue samples [565].
Darkfield Microscopy and Molecular Tests
Darkfield microscopy, while technically demanding, allows for the immediate visualization of T. pallidum spirochetes in lesion exudates. This method is highly specific when performed and interpreted correctly.
Molecular tests, specifically Nucleic Acid Amplification Tests (NAATs) like Polymerase Chain Reaction (PCR), offer another avenue for direct detection of T. pallidum DNA. Although commercially available NAATs for T. pallidum are not widely accessible, many laboratories have developed and validated their own PCR assays for this purpose. These PCR tests are highly sensitive and specific, providing rapid and accurate diagnosis of syphilis in early lesions.
Serological Diagnosis of Syphilis: Presumptive Methods
In routine clinical practice, presumptive diagnosis of syphilis relies on serological testing. This approach involves using two types of blood tests: a nontreponemal test and a treponemal test [566–568]. It’s critical to use both types of tests because using only one can lead to inaccurate results, including false negatives in primary syphilis and false positives in individuals without syphilis or those previously treated.
Nontreponemal Tests and the Traditional Algorithm
Nontreponemal tests, such as the Venereal Disease Research Laboratory (VDRL) test and the Rapid Plasma Reagin (RPR) test, detect antibodies to cardiolipin-lecithin-cholesterol antigens, which are released from damaged host cells as well as Treponema pallidum. These tests are inexpensive and easy to perform, making them useful for screening and monitoring treatment response. However, nontreponemal tests can yield false-positive results due to various conditions unrelated to syphilis, including HIV infection, autoimmune diseases, vaccinations, injection drug use, pregnancy, and older age [566, 569].
Therefore, according to the traditional algorithm for diagnosis of syphilis, a reactive nontreponemal test must always be followed by a treponemal test to confirm the diagnosis. Nontreponemal antibody titers often correlate with disease activity and are used to assess treatment efficacy. Serial dilutions of serum are performed to determine the highest titer, and results should be reported quantitatively. A fourfold change in titer, equivalent to a two-dilution change (e.g., from 1:16 to 1:4 or 1:8 to 1:32), is considered a clinically significant difference, indicating treatment response or disease progression. For consistent monitoring, sequential serologic tests should be performed using the same test (VDRL or RPR), preferably by the same laboratory. While VDRL and RPR tests are equally valid, their quantitative results are not directly comparable due to methodological differences, with RPR titers often being slightly higher than VDRL titers.
Typically, nontreponemal test titers decrease after successful treatment and may become nonreactive over time. However, in some individuals, titers may decline less than fourfold (inadequate serologic response) or persist at low levels indefinitely without seroreversion. Atypical serologic results, such as unusually high, low, or fluctuating titers, can occur regardless of HIV status. When serologic findings are inconsistent with clinical presentations of primary, secondary, or latent syphilis, presumptive treatment is recommended for individuals with syphilis risk factors. In such cases, additional diagnostic tests like lesion biopsy for histology, immunostaining, and PCR should be considered. In most HIV-infected individuals, serologic tests remain reliable for diagnosis of syphilis and monitoring treatment response.
Treponemal Tests and the Reverse Sequence Algorithm
Treponemal tests, such as the T. pallidum passive particle agglutination (TP-PA) assay, enzyme immunoassays (EIAs), chemiluminescence immunoassays (CIAs), immunoblots, and rapid treponemal assays, detect antibodies specifically directed against T. pallidum antigens. At least 18 treponemal-specific tests are approved for use in the United States. While highly specific for syphilis, treponemal tests typically remain reactive for life in most patients, even after successful treatment and regardless of disease activity. However, in 15%–25% of patients treated during primary syphilis, treponemal tests may revert to nonreactive after 2–3 years [570]. Treponemal antibody titers do not predict treatment response and should not be used for this purpose.
The reverse sequence algorithm for diagnosis of syphilis has become increasingly common in clinical laboratories. This approach begins with a treponemal immunoassay (usually EIA or CIA) as the screening test [571–573]. The reverse algorithm is effective in identifying individuals with past syphilis exposure, including those previously treated, those with untreated or incompletely treated syphilis, and those with false-positive screening results, which can occur with low likelihood of actual infection [574].
In the reverse algorithm, a positive treponemal screening test is followed by a quantitative nontreponemal test (RPR or VDRL) performed reflexively by the laboratory to guide patient management. If the nontreponemal test is reactive, it generally indicates active syphilis or recent infection. If the nontreponemal test is nonreactive, a second, different treponemal test, preferably TP-PA or a treponemal assay using different antigens than the initial test, should be performed to resolve discordant results.
If the second treponemal test is positive (e.g., EIA reactive, RPR nonreactive, TP-PA reactive), individuals with a history of previous syphilis treatment generally require no further intervention unless their sexual history suggests possible re-exposure. In cases of potential re-exposure, a repeat nontreponemal test 2–4 weeks after a thorough medical history and physical examination is recommended to evaluate for early reinfection. Individuals without a history of syphilis treatment should be offered treatment. Unless there is evidence of recent infection from medical history or physical examination, previously untreated individuals should be treated for syphilis of unknown duration or late latent syphilis.
If the second treponemal test is negative (e.g., EIA reactive, RPR nonreactive, TP-PA nonreactive) and the patient has a low epidemiologic risk and clinical probability of syphilis, further evaluation or treatment is typically not indicated.
Studies have shown that high quantitative index values or signal-to-cutoff ratios from treponemal EIA or CIA tests are strongly correlated with TP-PA positivity. This correlation may obviate the need for additional confirmatory testing in some cases. However, the specific index value ranges vary among different treponemal immunoassays, and the reactivity levels corresponding to confirmatory test positivity may differ depending on the immunoassay used [567, 575–582].
Cerebrospinal Fluid (CSF) Evaluation for Neurosyphilis
Cerebrospinal fluid (CSF) evaluation is crucial in the diagnosis of syphilis when neurosyphilis is suspected. CSF examination is warranted for individuals presenting with clinical signs of neurosyphilis, such as cranial nerve dysfunction, meningitis, stroke, acute or chronic altered mental status, or loss of vibration sense. All patients with ocular syphilis and reactive syphilis serology require a comprehensive ocular examination, including cranial nerve assessment. If cranial nerve dysfunction is present in ocular syphilis, CSF evaluation becomes necessary. However, in cases of isolated ocular symptoms (without cranial nerve dysfunction or other neurological abnormalities), confirmed ocular abnormalities on examination, and reactive syphilis serology, routine CSF examination before treatment is generally not required. CSF analysis can be valuable in evaluating patients with ocular symptoms and reactive syphilis serology who lack ocular findings or cranial nerve dysfunction on examination. For patients with isolated auditory abnormalities and reactive syphilis serology (otosyphilis), CSF evaluation is likely to be normal and is typically unnecessary before initiating treatment [583, 584].
Laboratory testing of CSF is an important adjunct in supporting the diagnosis of syphilis involving the CNS; however, no single CSF test is universally diagnostic for neurosyphilis. The diagnosis depends on a combination of CSF findings (e.g., elevated CSF cell count, protein, or reactive CSF-VDRL) in conjunction with reactive serum serologic test results (both nontreponemal and treponemal) and clinical neurologic signs and symptoms. CSF abnormalities are commonly observed in early syphilis but are of uncertain clinical significance in the absence of neurologic symptoms [585]. The CSF-VDRL test is highly specific for neurosyphilis but has limited sensitivity. A reactive CSF-VDRL in a patient with neurologic signs or symptoms (and without blood contamination of the CSF sample) is considered diagnostic of neurosyphilis.
When CSF-VDRL is nonreactive despite clinical suspicion of neurosyphilis, reactive serum serologic tests, and CSF findings of lymphocytic pleocytosis or elevated protein, neurosyphilis should still be considered. In such instances, further CSF evaluation using fluorescent treponemal antibody absorption (FTA-ABS) or TP-PA testing may be warranted. The CSF FTA-ABS test is less specific for neurosyphilis than CSF-VDRL but exhibits high sensitivity. Data on CSF TP-PA are less extensive, but its sensitivity and specificity appear similar to those of CSF FTA-ABS [586]. Neurosyphilis is highly improbable with a negative CSF FTA-ABS or TP-PA test, especially in individuals with nonspecific neurologic signs and symptoms [587].
In HIV-infected individuals, CSF leukocyte counts may be elevated (>5 WBCs/mm3). The correlation between CSF leukocyte count and plasma HIV viral suppression is not fully understood. Using a higher CSF leukocyte cutoff (>20 WBCs/mm3) might improve the specificity of neurosyphilis diagnosis of syphilis in this population [588].
Key Considerations in Syphilis Diagnosis
False Positives and False Negatives
Understanding the potential for false-positive and false-negative results is crucial in the diagnosis of syphilis. False-positive nontreponemal tests are more common and can be triggered by various factors. False-negative results, especially in early primary syphilis before seroconversion, can occur if testing is performed too soon after infection. Clinical context, risk factors, and repeat testing are essential in navigating these diagnostic challenges.
Syphilis Diagnosis in HIV-infected Individuals
Diagnosis of syphilis in individuals with HIV infection is generally reliable using standard serologic tests. However, clinicians should be aware of atypical serologic responses and the potential for higher false-positive rates in nontreponemal tests within this population. Neurosyphilis may also present differently in HIV-infected individuals, and higher CSF WBC cutoffs may be considered to improve diagnostic specificity.
Diagnosis of Ocular and Otosyphilis
Ocular and otosyphilis require a high index of suspicion for diagnosis of syphilis. These forms of syphilis can occur at any stage and may not always be accompanied by systemic or neurological signs. A thorough ophthalmologic or audiologic examination, combined with appropriate syphilis serology, is crucial for accurate diagnosis and prompt treatment to prevent permanent vision or hearing loss.
Conclusion
Accurate diagnosis of syphilis is fundamental to effective patient management and public health efforts to control this sexually transmitted infection. A multifaceted approach, incorporating clinical evaluation, direct detection methods when appropriate, and serologic testing algorithms, is essential. Understanding the nuances of nontreponemal and treponemal tests, the role of CSF evaluation in suspected neurosyphilis, and special considerations for specific patient populations ensures timely and accurate diagnosis, leading to appropriate treatment and prevention of long-term sequelae of syphilis.
[564] … (Original citation from article)
[565] … (Original citation from article)
[566] … (Original citation from article)
[567] … (Original citation from article)
[568] … (Original citation from article)
[569] … (Original citation from article)
[570] … (Original citation from article)
[571] … (Original citation from article)
[572] … (Original citation from article)
[573] … (Original citation from article)
[574] … (Original citation from article)
[575] … (Original citation from article)
[576] … (Original citation from article)
[577] … (Original citation from article)
[578] … (Original citation from article)
[579] … (Original citation from article)
[580] … (Original citation from article)
[581] … (Original citation from article)
[582] … (Original citation from article)
[583] … (Original citation from article)
[584] … (Original citation from article)
[585] … (Original citation from article)
[586] … (Original citation from article)
[587] … (Original citation from article)
[588] … (Original citation from article)
[589] … (Original citation from article)
[590] … (Original citation from article)
